Informazioni generali
  • Categoria della malattia Cancro del polmone (BASEC)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Zurigo
    (BASEC)
  • Responsabile dello studio PD Dr. med. Thomas Gaisl, PhD thomas.gaisl@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 16.10.2025 ICTRP: N/A
  • Ultimo aggiornamento 16.10.2025 14:05
HumRes67144 | SNCTP000006542 | BASEC2025-D0037

Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System

  • Categoria della malattia Cancro del polmone (BASEC)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Zurigo
    (BASEC)
  • Responsabile dello studio PD Dr. med. Thomas Gaisl, PhD thomas.gaisl@usz.ch (BASEC)
  • Fonte dati BASEC: Importato da 16.10.2025 ICTRP: N/A
  • Ultimo aggiornamento 16.10.2025 14:05

Descrizione riassuntiva dello studio

The purpose of this study is to collect data to understand how accurately medical professionals utilize the Ion Endoluminal System, imaging (e.g., CT scan), and other medical skills during a bronchoscopic lung biopsy or localization procedure. The Ion Endoluminal System has been approved for use in bronchoscopy in the European Union, the United Kingdom, and Switzerland since 2023. It is a robotic bronchoscopy system. The data will help to understand standard practices in different regions of Europe. It will also show the diagnostic and therapeutic pathway of patients with a lung nodule after treatment with the Ion Endoluminal System. Up to 1200 individuals will be included in this study across approximately 12 different participating hospitals in Europe. All data collected in this study will be routinely collected by your clinic, and no examinations will be conducted specifically for the purposes of this study. Depending on your procedure (lung biopsy or localization procedure) and the outcome of the tissue sample (cancer or no cancer), the study will last either 12 or 24 months.

(BASEC)

Intervento studiato

The Ion Endoluminal System has been approved for use in bronchoscopy in the European Union, the United Kingdom, and Switzerland since 2023. It is a robotic bronchoscopy system consisting of a thin plastic tube known as a catheter. The catheter has a sensor that indicates its position in the lung and guides the physician during the procedure. The robotic arm allows your physician to maneuver the catheter within your airways and stabilize the catheter during the procedure. The system does not perform any movement or activity without input and control from your physician.

Once the targeted nodule is reached, your physician will take a tissue sample for analysis using instruments (e.g., needle or forceps). If you undergo a localization procedure, your physician will place a marker through the catheter near the nodule.

 

No part of this study involves an experimental device or procedure. The Ion Endoluminal System is routinely used by your physician for this procedure.

(BASEC)

Malattie studiate

Lung Nodule

(BASEC)

Criteri di partecipazione
1. The patient is 18 years of age or older at the time of consent. 2. The patient is planned for a biopsy of a lung lesion and/or a localization procedure using the Ion Endoluminal System. 3. The patient is willing and able to provide written informed consent to participate in the clinical study. (BASEC)

Criteri di esclusione
1. The patient is participating in an interventional research study or a research study involving investigational products with unknown safety profiles that would affect participation in this study or study outcomes. 2. Female patient who is pregnant or breastfeeding; determined by the standard practice of the study center. 3. The patient is legally incompetent or is, by court order, in an institution or belongs to a known vulnerable population, including but not limited to dependence on the sponsor, hospital, or investigator. 4. The patient is not willing to meet the participation conditions following the study procedure. 5. The investigator has determined in their professional opinion that it is in the best interest of the patient not to participate in the study. (BASEC)

Luogo dello studio

Zurigo

(BASEC)

non disponibile

Sponsor

Intuitive Surgical Sàrl

(BASEC)

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

PD Dr. med. Thomas Gaisl, PhD

+41 43 253 17 32

thomas.gaisl@usz.ch

Universitätsspital Zürich, Klinik für Pneumologie Rämistrasse 100, 8091 Zürich

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione etica Zurigo

(BASEC)

Data di approvazione del comitato etico

19.08.2025

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
A European Multi-Center, Prospective, Single-Arm, Observational Study to Evaluate Real-World Outcomes for the Ion Endoluminal System (BASEC)

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile